Literature DB >> 18987351

Mutations in GBA are associated with familial Parkinson disease susceptibility and age at onset.

W C Nichols1, N Pankratz, D K Marek, M W Pauciulo, V E Elsaesser, C A Halter, A Rudolph, J Wojcieszek, R F Pfeiffer, T Foroud.   

Abstract

OBJECTIVE: To characterize sequence variation within the glucocerebrosidase (GBA) gene in a select subset of our sample of patients with familial Parkinson disease (PD) and then to test in our full sample whether these sequence variants increased the risk for PD and were associated with an earlier onset of disease.
METHODS: We performed a comprehensive study of all GBA exons in one patient with PD from each of 96 PD families, selected based on the family-specific lod scores at the GBA locus. Identified GBA variants were subsequently screened in all 1325 PD cases from 566 multiplex PD families and in 359 controls.
RESULTS: Nine different GBA variants, five previously reported, were identified in 21 of the 96 PD cases sequenced. Screening for these variants in the full sample identified 161 variant carriers (12.2%) in 99 different PD families. An unbiased estimate of the frequency of the five previously reported GBA variants in the familial PD sample was 12.6% and in the control sample was 5.3% (odds ratio 2.6; 95% confidence interval 1.5-4.4). Presence of a GBA variant was associated with an earlier age at onset (p = 0.0001). On average, those patients carrying a GBA variant had onset with PD 6.04 years earlier than those without a GBA variant.
CONCLUSIONS: This study suggests that GBA is a susceptibility gene for familial Parkinson disease (PD) and patients with GBA variants have an earlier age at onset than patients with PD without GBA variants.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18987351      PMCID: PMC2677501          DOI: 10.1212/01.wnl.0000327823.81237.d1

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  31 in total

1.  Glucocerebrosidase mutations are also found in subjects with early-onset parkinsonism from Venezuela.

Authors:  Michael J Eblan; Joann Nguyen; Shira G Ziegler; Alicia Lwin; Melissa Hanson; Marisol Gallardo; Roberto Weiser; Marisel De Lucca; Andrew Singleton; Ellen Sidransky
Journal:  Mov Disord       Date:  2006-02       Impact factor: 10.338

2.  Glucocerebrosidase mutations are an important risk factor for Lewy body disorders.

Authors:  O Goker-Alpan; B I Giasson; M J Eblan; J Nguyen; H I Hurtig; V M-Y Lee; J Q Trojanowski; E Sidransky
Journal:  Neurology       Date:  2006-06-21       Impact factor: 9.910

3.  Glucocerebrosidase mutations and risk of Parkinson disease in Chinese patients.

Authors:  Eng-King Tan; Justina Tong; Stephanie Fook-Chong; Yuen Yih; Meng-Cheong Wong; Ratnagopal Pavanni; Yi Zhao
Journal:  Arch Neurol       Date:  2007-07

Review 4.  Gaucher disease.

Authors:  Terry D Butters
Journal:  Curr Opin Chem Biol       Date:  2007-07-23       Impact factor: 8.822

5.  Mutations in the glucocerebrosidase gene are associated with early-onset Parkinson disease.

Authors:  L N Clark; B M Ross; Y Wang; H Mejia-Santana; J Harris; E D Louis; L J Cote; H Andrews; S Fahn; C Waters; B Ford; S Frucht; R Ottman; K Marder
Journal:  Neurology       Date:  2007-09-18       Impact factor: 9.910

6.  LRRK2 mutation analysis in Parkinson disease families with evidence of linkage to PARK8.

Authors:  W C Nichols; V E Elsaesser; N Pankratz; M W Pauciulo; D K Marek; C A Halter; A Rudolph; C W Shults; T Foroud
Journal:  Neurology       Date:  2007-09-05       Impact factor: 9.910

7.  Glucocerebrosidase gene mutations are associated with Parkinson's disease in southern Italy.

Authors:  Elvira V De Marco; Grazia Annesi; Patrizia Tarantino; Francesca E Rocca; Giovanni Provenzano; Donatella Civitelli; Innocenza C Cirò Candiano; Ferdinanda Annesi; Sara Carrideo; Francesca Condino; Giuseppe Nicoletti; Demetrio Messina; Fabiana Novellino; Maurizio Morelli; Aldo Quattrone
Journal:  Mov Disord       Date:  2008-02-15       Impact factor: 10.338

8.  Glucocerebrosidase mutations in Chinese subjects from Taiwan with sporadic Parkinson disease.

Authors:  Shira G Ziegler; Michael J Eblan; Usha Gutti; Kathleen S Hruska; Barbara K Stubblefield; Ozlem Goker-Alpan; Mary E LaMarca; Ellen Sidransky
Journal:  Mol Genet Metab       Date:  2007-04-25       Impact factor: 4.797

9.  Glucocerebrosidase gene mutation is a risk factor for early onset of Parkinson disease among Taiwanese.

Authors:  Yih-Ru Wu; Chiung-Mei Chen; Chih-Ying Chao; Long-Sun Ro; Rong-Kuo Lyu; Kuo-Hsuan Chang; Guey-Jen Lee-Chen
Journal:  J Neurol Neurosurg Psychiatry       Date:  2007-09       Impact factor: 10.154

10.  Glucocerebrosidase gene mutations and Parkinson disease in the Norwegian population.

Authors:  M Toft; L Pielsticker; O A Ross; J O Aasly; M J Farrer
Journal:  Neurology       Date:  2006-02-14       Impact factor: 9.910

View more
  93 in total

1.  Developmental exposure to organophosphates triggers transcriptional changes in genes associated with Parkinson's disease in vitro and in vivo.

Authors:  Theodore A Slotkin; Frederic J Seidler
Journal:  Brain Res Bull       Date:  2011-09-28       Impact factor: 4.077

Review 2.  The role of glucocerebrosidase mutations in Parkinson disease and Lewy body disorders.

Authors:  Arash Velayati; W Haung Yu; Ellen Sidransky
Journal:  Curr Neurol Neurosci Rep       Date:  2010-05       Impact factor: 5.081

Review 3.  Parkinson's disease dementia and potential therapeutic strategies.

Authors:  John N Caviness; LihFen Lue; Charles H Adler; Douglas G Walker
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

4.  GBA Variants are associated with a distinct pattern of cognitive deficits in Parkinson's disease.

Authors:  Ignacio F Mata; James B Leverenz; Daniel Weintraub; John Q Trojanowski; Alice Chen-Plotkin; Vivianna M Van Deerlin; Beate Ritz; Rebecca Rausch; Stewart A Factor; Cathy Wood-Siverio; Joseph F Quinn; Kathryn A Chung; Amie L Peterson-Hiller; Jennifer G Goldman; Glenn T Stebbins; Bryan Bernard; Alberto J Espay; Fredy J Revilla; Johnna Devoto; Liana S Rosenthal; Ted M Dawson; Marilyn S Albert; Debby Tsuang; Haley Huston; Dora Yearout; Shu-Ching Hu; Brenna A Cholerton; Thomas J Montine; Karen L Edwards; Cyrus P Zabetian
Journal:  Mov Disord       Date:  2015-08-21       Impact factor: 10.338

Review 5.  The association between mutations in the lysosomal protein glucocerebrosidase and parkinsonism.

Authors:  John DePaolo; Ozlem Goker-Alpan; Ted Samaddar; Grisel Lopez; Ellen Sidransky
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

Review 6.  GBA-Associated Parkinson's Disease and Other Synucleinopathies.

Authors:  Ziv Gan-Or; Christopher Liong; Roy N Alcalay
Journal:  Curr Neurol Neurosci Rep       Date:  2018-06-08       Impact factor: 5.081

7.  Cognitive and motor functioning in elderly glucocerebrosidase mutation carriers.

Authors:  Eileen E Moran; Cuiling Wang; Mindy Katz; Laurie Ozelius; Alison Schwartz; Jelena Pavlovic; Roberto A Ortega; Richard B Lipton; Molly E Zimmerman; Rachel Saunders-Pullman
Journal:  Neurobiol Aging       Date:  2017-06-24       Impact factor: 4.673

Review 8.  Genetic convergence of Parkinson's disease and lysosomal storage disorders.

Authors:  Hao Deng; Xiaofei Xiu; Joseph Jankovic
Journal:  Mol Neurobiol       Date:  2014-08-07       Impact factor: 5.590

9.  The p.L302P mutation in the lysosomal enzyme gene SMPD1 is a risk factor for Parkinson disease.

Authors:  Ziv Gan-Or; Laurie J Ozelius; Anat Bar-Shira; Rachel Saunders-Pullman; Anat Mirelman; Ruth Kornreich; Mali Gana-Weisz; Deborah Raymond; Liron Rozenkrantz; Andres Deik; Tanya Gurevich; Susan J Gross; Nicole Schreiber-Agus; Nir Giladi; Susan B Bressman; Avi Orr-Urtreger
Journal:  Neurology       Date:  2013-03-27       Impact factor: 9.910

10.  Transcranial sonography and functional imaging in glucocerebrosidase mutation Parkinson disease.

Authors:  M J Barrett; J Hagenah; V Dhawan; S Peng; K Stanley; D Raymond; A Deik; S J Gross; N Schreiber-Agus; A Mirelman; K Marder; L J Ozelius; D Eidelberg; S B Bressman; R Saunders-Pullman
Journal:  Parkinsonism Relat Disord       Date:  2012-10-10       Impact factor: 4.891

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.